USPTO serial 50063040
NANOSENSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with NANOSENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Palo Alto, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SHAILENDRA K MAHESHWARI
SHAILENDRA K MAHESHWARI SELF12322 Pissaro DriveN. Potomac, MD 20878United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biocompatible plasmonic and magnetoelectric nanoparticles for use in brain-computer interface (BCI) systems, for integration with human brain tissue to enable non-invasive stimulation and recording of neural activity, and for real-time diagnostics for enhanced neurological treatments. | ACTIVE | — |
| 010 | Medical devices featuring non-surgical, biocompatible nanoparticles for the treatment of neurological and neurodegenerative diseases through targeted brain stimulation; Brain-computer interface devices for medical use, designed to restore motor functions and enhance cognitive rehabilitation therapies; Health monitoring devices utilizing brain-computer interface (BCI) technology for real-time brain activity analysis and diagnostics, aiding in the treatment and understanding of neurological disorders; Medical devices for providing neurofeedback and biofeedback, supporting therapeutic interventions and cognitive enhancement. | ACTIVE | — |
| 042 | Software as a service (SaaS) services, including design and development, featuring non-downloadable software for use with brain-computer interface (BCI) devices and systems, enabling non-invasive neural activity stimulation and recording, signal capture and transmission, thought-controlled digital device interaction, enhanced human-machine integration, real-time brain activity monitoring, cognitive function enhancement, cognitive rehabilitation therapies, and improved accessibility for individuals with physical limitations; Research and development services in the field of brain-computer interfaces and biocompatible nanoparticle technology for enhancing human cognition and interaction with technology; Providing technology-based services and consultation, namely, development of technologies utilizing brain-computer interface (BCI) systems for real-time neural activity monitoring, aiding in the early detection and diagnosis of neurological conditions. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 20, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 20, 2026 | NWAP | NEW APPLICATION ENTERED | — |